ÂÜÀòÂÒÂ×

Adrian Martins has a diverse work experience in the field of clinical data management. Adrian started their career at CHU Montpellier as a Stagiaire Attaché de Recherche Clinique from January 2017 to February 2017. Afterwards, they joined the Centre d'investigation clinique de Limoges as an Attaché de recherche clinique for a brief period from April 2017 to August 2017. In 2016, Adrian was a student at faculté de pharmacie de Montpellier, where they gained knowledge and skills in various aspects of the pharmaceutical industry, particularly in research clinical. Finally, Adrian joined Cytel in 2018 as a Clinical Data Manager and later progressed to the role of Senior Clinical Data Manager in March 2023.

Adrian Martins has a diverse education background in the field of healthcare and data management. In 2013, they obtained a Bachelor's degree in Biochemistry and Molecular Biology, specializing in Health, from the University of Tours. From 2016 to 2017, Adrian pursued a Master's degree in Health Engineering with a focus on Clinical Operations Management and Data Management at the University of Montpellier. Adrian furthered their education by completing a Master's degree in Health Engineering with a specialization in Data Management for Clinical Research and Development at the Faculty of Pharmacy in Montpellier from 2017 to 2018.

In addition to their academic qualifications, Adrian has also obtained several certifications related to their field. Adrian became a Certified Designer Data Migrator from Merative Clinical Development in February 2022, and earlier in June 2021, they acquired a certification as a Certified Designer in Inventory/Dispensing Management. Adrian also attained the designation of Certified Designer in Endpoint Adjudication in February 2021. Furthermore, in January 2020, they received a Certified Designer certification from Merative Clinical Development. Finally, it is worth noting that Adrian holds a Master's degree in Health Engineering with a specialization in Data Management for Clinical Research and Development from the Faculty of Pharmacy in Montpellier, although the specific month and year of its acquisition are not provided in the information given.